Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Engman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Anticancer Research|May 1, 1992
Tolerance to long-term treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferonB Ahren, K Engman, A Lindblom
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Leukocyte interferon in the treatment of chronic myelogenous leukemia in second chronic phaseA Wahlin, J Holm, K Engman
Anticancer Research|January 1, 1992
Treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferonB Ahren, K Engman, A Lindblom
Scandinavian Journal of Plastic and Reconstructive Surgery|January 1, 1984
Psychological aspects of breast reconstruction following mastectomyC O Jonsson, K Engman, O Asplund
Scandinavian Journal of Infectious Diseases|January 1, 1995
Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: a pilot studyJ H Braconier, O Paulsen, K Engman, et al.
British Journal of Cancer|May 14, 1998
Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifenR Henriksson, S Nilsson, S Colleen, et al.
The Journal of Infectious Diseases|April 1, 1991
Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudineO Berglund, K Engman, A Ehrnst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II studyF Donskov, H von der Maase, R Henriksson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Anticancer Research|May 1, 1992
Tolerance to long-term treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferonB Ahren, K Engman, A Lindblom
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Leukocyte interferon in the treatment of chronic myelogenous leukemia in second chronic phaseA Wahlin, J Holm, K Engman
Anticancer Research|January 1, 1992
Treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferonB Ahren, K Engman, A Lindblom
Scandinavian Journal of Plastic and Reconstructive Surgery|January 1, 1984
Psychological aspects of breast reconstruction following mastectomyC O Jonsson, K Engman, O Asplund
Scandinavian Journal of Infectious Diseases|January 1, 1995
Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: a pilot studyJ H Braconier, O Paulsen, K Engman, et al.
British Journal of Cancer|May 14, 1998
Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifenR Henriksson, S Nilsson, S Colleen, et al.
The Journal of Infectious Diseases|April 1, 1991
Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudineO Berglund, K Engman, A Ehrnst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II studyF Donskov, H von der Maase, R Henriksson, et al.
Pageof 1